Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis

BACKGROUND: A high percentage of patients with COPD report chronic nasal symptoms. The study aims to evaluate the clinical impact of a 2-month treatment with inhaled nasal budesonide (100 µg per nostril twice daily) in patients affected by COPD with chronic rhinitis comorbidity. PATIENTS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrese, Cecilia, Costigliola, Adriano, Maffei, Marianna, Simeon, Vittorio, Perna, Francesco, Tremante, Eugenio, Merola, Elena, Leone, Carlo Antonio, Bianco, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029594/
https://www.ncbi.nlm.nih.gov/pubmed/29988687
http://dx.doi.org/10.2147/COPD.S165857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029594/
https://www.ncbi.nlm.nih.gov/pubmed/29988687
http://dx.doi.org/10.2147/COPD.S165857

Ejemplares similares